✦ LIBER ✦

The pharmacology of Parkinson's disease: l-dopa and beyond

✍ Scribed by Peter Riederer; Gavin P. Reynolds; Kurt Jellinger

Book ID: 119111276
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 481 KB
Volume: 5
Category: Article
ISSN: 0165-6147
DOI: 10.1016/0165-6147(84)90355-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Bereitschaftspotential, l-DOPA and p

The Bereitschaftspotential, l-DOPA and parkinson's disease

✍ J.P.R Dick; R Cantello; O Buruma; M Gioux; R Benecke; B.L Day; J.C Rothwell; P.D 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 899 KB

EFFECTS OF L-DOPA IN PARKINSON'S DISEASE

✍ Godwin-Austen, R.B; Frears, C.C; Tomlinson, E.B; Kok, H.W.L 📂 Article 📅 1969 🏛 The Lancet 🌐 English ⚖ 570 KB

Codrugs Linking l -Dopa and Sulfur-Conta

Codrugs Linking l -Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease

✍ Pinnen, Francesco; Cacciatore, Ivana; Cornacchia, Catia; Sozio, Piera; Cerasa, L 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 119 KB

Focusing effects of L-dopa in Parkinson'

Focusing effects of L-dopa in Parkinson's disease

✍ Bernard Ng; Samantha Palmer; Rafeef Abugharbieh; Martin J. McKeown 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 397 KB

## Abstract Previous fMRI motor studies in Parkinson's disease (PD) have suggested that L‐dopa may “normalize” areas of hypo‐ and hyperactivity. However, results from these studies, which were largely based on analyzing BOLD signal amplitude, have been conflicting. Examining only amplitude changes

Monitoring of L-dopa concentrations in p

Monitoring of L-dopa concentrations in parkinson’s disease

✍ M. Furlanut; M. Furlanut jr; P. Benetello 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 88 KB

l-DOPA's mechanism of action in Parkinso

l-DOPA's mechanism of action in Parkinson's disease

✍ Franz Hefti; Eldad Melamed 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 497 KB